1. Açık Erişim@BUU
  2. İndeksli Yayınlar
  3. Web of Science
Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/33415
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBoz, Cavit-
dc.contributor.authorÖzakbaş, Serkan-
dc.contributor.authorTerzi, Murat-
dc.contributor.authorTürkoğlu, Recai-
dc.contributor.authorAkman, Gülşen-
dc.contributor.authorEfendi, Hüsnü-
dc.contributor.authorAkçalı, Aylin-
dc.contributor.authorTuncer, Alaettin-
dc.contributor.authorYüceyar, Nur-
dc.contributor.authorSoysal, Aysun-
dc.contributor.authorKöseoğlu, M.-
dc.contributor.authorBalcı, Belgin Petek-
dc.contributor.authorSevim, Serhan-
dc.contributor.authorAltıntaş, Ayşe-
dc.contributor.authorÇilingir, Vedat-
dc.contributor.authorDemirkıran, Meltem-
dc.contributor.authorKızılay, Ferah-
dc.contributor.authorAltunrende, Burcu-
dc.date.accessioned2023-08-08T13:31:23Z-
dc.date.available2023-08-08T13:31:23Z-
dc.date.issued2017-10-
dc.identifier.citationBoz, C. vd. (2017). ''Real world efficacy and safety of teriflunomide in patients with relapsing-remitting multiple sclerosis''. Multiple Sclerosis Journal, 23(Supplement 3), 327-328.en_US
dc.identifier.issn1352-4585-
dc.identifier.issn1477-0970-
dc.identifier.urihttps://journals.sagepub.com/toc/msja/23/3_suppl-
dc.identifier.urihttp://hdl.handle.net/11452/33415-
dc.descriptionBu çalışma, 25-28, Ekim 2017 tarihlerinde Paris[Fransa]’ de düzenlenen 7. Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) Kongresi‘nde bildiri olarak sunulmuştur.tr_TR
dc.description.sponsorshipMerck & Companyen_US
dc.description.sponsorshipNovartisen_US
dc.description.sponsorshipBayer AGen_US
dc.description.sponsorshipTeva Pharmaceutical Industriesen_US
dc.description.sponsorshipEuropean Comm Treatment & Res Multiple Sclerosisen_US
dc.description.sponsorshipAmericas Comm Treatment & Res Multiple Sclerosisen_US
dc.language.isoenen_US
dc.publisherSage Puplicationsen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectNeurosciences & neurologyen_US
dc.titleReal world efficacy and safety of teriflunomide in patients with relapsing-remitting multiple sclerosisen_US
dc.typeMeeting Abstracten_US
dc.identifier.wos000413730202068tr_TR
dc.relation.publicationcategoryKonferans Öğesi - Uluslararasıtr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Nöroloji Anabilim Dalı.tr_TR
dc.identifier.startpage327tr_TR
dc.identifier.endpage328tr_TR
dc.identifier.volume23tr_TR
dc.identifier.issueSuplement 3en_US
dc.relation.journalMultiple Sclerosis Journalen_US
dc.contributor.buuauthorTuran, Ömer Faruk-
dc.relation.collaborationYurt içitr_TR
dc.relation.collaborationSanayitr_TR
dc.subject.wosClinical neurologyen_US
dc.subject.wosNeurosciencesen_US
dc.indexed.wosSCIEen_US
dc.indexed.wosCPCISen_US
dc.wos.quartileQ1en_US
Appears in Collections:Web of Science

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.